A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes - Rosenstock, J; Davies, M; Home, P; Larsen, J; Koenen, C; Schernthaner, G (Diabetologia, 2008)